11 Results for "

Orphenadrine hydrochloride

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Orphenadrine hydrochloride" in MCE Product Catalog:

Cat. No.: HY-B1126
CAS No.: 341-69-5
Target:  

iGluR

Research Areas:  

Neurological Disease Cancer

Orphenadrine hydrochloride is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine hydrochloride relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine hydrochloride is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-B0369A
CAS No.: 4682-36-4
Target:  

iGluR

Research Areas:  

Neurological Disease Cancer

Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-157959
CAS No.: 83-98-7
Synonyms: (±)-Orphenadrine
Orphenadrine ((±)-Orphenadrine) is a skeletal muscle relaxant and NMDA antagonist that also has antiparkinsonian, antihistamine, antitremor, antispasmodic, and analgesic effects. Orphenadrine inhibits the binding of [3H]MK-801 to the phencyclidine (PCP) binding site of the NMDA receptor. Orphenadrine is also an anticholinergic and CYP2B inducer. Orphenadrine may exert pro-tumor effects, causing CAR nuclear translocation, resulting in microsomal reactive oxygen species (ROS) production and oxidative stress. Orphenadrine also exerts neuronal protection, protecting rat cerebellar granule cells (CGC) from 3-NPA-induced death and has inhibitory potential against neurodegenerative diseases mediated by NMDA receptor overactivation .
loading...
    loading...
Cat. No.: HY-143861S
CAS No.: 1185011-75-9
Orphenadrine-d3 is the deuterium labeled Orphenadrine .
loading...
    loading...
Cat. No.: HY-B1126S
CAS No.: 1309283-23-5
Orphenadrine-d3 (hydrochloride) is the deuterium labeled Orphenadrine hydrochloride . Orphenadrine hydrochloride is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine hydrochloride relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine hydrochloride is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-B1126R
CAS No.: 341-69-5
Research Areas:  

Neurological Disease Cancer

Orphenadrine (hydrochloride) (Standard) is the analytical standard of Orphenadrine (hydrochloride). This product is intended for research and analytical applications. Orphenadrine hydrochloride is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine hydrochloride relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine hydrochloride is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-B0369AS
Orphenadrine-d3 (citrate) is the deuterium labeled Orphenadrine citrate. Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
loading...
    loading...
Cat. No.: HY-B0369AR
CAS No.: 4682-36-4
Research Areas:  

Neurological Disease

Orphenadrine (citrate) (Standard) is the analytical standard of Orphenadrine (citrate). This product is intended for research and analytical applications. Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-144142S
Orphenadrine impurity 6-d3 (hydrochloride) is the deuterium labeled Orphenadrine impurity 6 hydrochloride .
loading...
    loading...
Cat. No.: HY-W740116
CAS No.: 10488-36-5
Synonyms: TOF hydrochloride
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Tofenacin hydrochloride (TOF hydrochloride) is an orally active weak anticholinergic compound. Tofenacin hydrochloride can be used to study extrapyramidal symptoms and depressive side effects associated with the use of Fluphenazine decanoate (HY-B1904) .
loading...
    loading...
Cat. No.: HY-W740116A
CAS No.: 15301-93-6
Synonyms: TOF
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Tofenacin (TOF) is an orally active weak anticholinergic compound. Tofenacin can be used to study extrapyramidal symptoms and depressive side effects associated with the use of Fluphenazine decanoate (HY-B1904) .
loading...
    loading...
  • 1